MedTrace Logo

Betadine Pleurodesis Via Tunneled Pleural Catheters

NCT02975921 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2019-01-11

No results posted yet for this study

Summary

The purpose of this study is to determine whether betadine (povidone-iodine) instillation during routine indwelling Tunneled Pleural Catheter (TPC) placement is efficacious in promoting pleurodesis and thus reducing the time to TPC removal.

Conditions

  • Pleural Effusion
  • Pleurodesis
  • Malignant Pleural Effusion
  • Pleural Effusion Due to Congestive Heart Failure
  • Pleural Effusion in Conditions Classified Elsewhere
  • Pleural Effusions, Chronic

Interventions

DRUG

Povidone-Iodine

Intrapleural administration of Povidone-Iodine

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Jonathan T Puchalski, MD, MEd · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-31
Primary Completion
2020-09-30
Completion
2021-06-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02975921 on ClinicalTrials.gov